Announcements

Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In June 2026, eleven new journals released their inaugural issues and two transferred journals released their first issue as part of MDPI, covering the subjects of environmental & earth sciences, chemistry & materials science, public health & healthcare, engineering, medicine & pharmacology, and biology & life sciences. 

We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, enabling impactful open access scholarship. 

Please feel free to browse and discover more about the new journals below. 

We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).

Peer review is the invisible foundation of academic progress. The 2025 MDPI Top Reviewers are some of the key experts who helped build it.

We are honored to recognize 1000 individuals from our global community of 210,000 reviewers across 67 countries and territories—chosen for their commitment to rigorous, constructive peer review and the consistency of their contributions throughout 2025.

The Top Reviewers provided constructive and impartial feedback that makes research stronger and more impactful, and we are grateful for it.

The names of these reviewers are listed below in alphabetical order by first name:

(Note: we respected all privacy preferences, with part of nominees opting for limited attribution.)

To meet the demands of Endocrines’ rapid growth and ensure the publication of high-quality articles that are freely distributed within the community, we are currently recruiting Academic Editors worldwide to join our Editorial Board. If you would like to participate as an Editorial Board Member, please refer to the guide below and submit your application accordingly.

Eligibility criteria of applicants:

• Must have completed their doctorate/PhD degree;
• Must have published impactful work in the field of endocrinology;
• Must currently (at the time of application) be serving as an associate professor or professor in academia.

The main responsibilities of Editorial Board Members are as follows:

• Pre-screening and making decisions on new submissions related to their research interests;
• Setting up at least one Special Issue during their term or supervising Special Issues on a topic pertaining to their research field;
• Helping to garner suitable expert authors and inviting young scholars to join as Guest Editors or reviewers;
• Providing input or feedback regarding the journal’s policies;
• Helping to promote the journal among their peers or at conferences;
• Attending Board meetings to suggest strategies for the journal’s development;
• Reviewing manuscripts.

The benefits of becoming an Editorial Board Member include the following:

• A certificate recognizing you as an Editorial Board Member;
• Travel grants, offered to Editorial Board Members who make significant contributions to the journal;
• The opportunity to publish one paper per year free of charge in our journal and potential discounts for authors who are invited by you to submit papers;
• Organizing or promoting your own conferences using our SciForum platform;
• An expanded research network providing new insights, collaborations, and opportunities for future research projects.

Endocrines (ISSN 2673-396X) is an international, peer-reviewed, open access journal dedicated to the publication of high-quality scientific papers in the field of endocrinology. Endocrines has received its first Impact Factor of 2.2 for 2025. Endocrines ranks in Q3 in the “Endocrinology & Metabolism” category. Endocrines has a CiteScore of 3.0, following its inclusion in Scopus (Elsevier) in 2025. The CiteScore ranks Q2 in the “Medicine” category. For more information about the journal, please visit the following link: https://www.mdpi.com/journal/endocrines.

If you are interested in joining the Editorial Board of Endocrines, please send your full academic CV and a short cover letter that details your interest and enthusiasm for the position to endocrines@mdpi.com.

We are pleased to share that Endocrines (ISSN 2673-396X) has received its first Impact Factor of 2.2 in the Journal Citation Reports™ released by Clarivate™ in June 2026. Endocrines ranks in Q3 in the “Endocrinology and Metabolism” category. The achievement follows the journal’s inclusion into the Emerging Sources Citation Index (ESCI) within the Web of Science Core Collection.

The 2025 Journal Impact Factor is calculated by dividing the number of citations received in 2025 by all publications in the journal from 2023 and 2024 by the total number of citable publications in those years.

To learn more, visit our journal statistics website for detailed metrics.

This milestone belongs to the editors, reviewers, authors, and readers who have shaped the journal. Thank you.

Endocrines (ISSN 2673-396X) is dedicated to publishing original, novel, and high-impact contributions pertaining to the field of endocrinology, covering diabetes, obesity, metabolism, reproduction and pregnancy, thyroid, adrenal, and bone metabolism.

All papers are in an open access format, granting our readers free and unlimited access to the full text of all the articles published in our journal. We welcome you to read our top cited papers published in 2025, which are listed below.

1. “Endocrine Toxicity of Micro- and Nanoplastics, and Advances in Detection Techniques for Human Tissues: A Comprehensive Review”
by Sabrina Bossio, Silvestro Antonio Ruffolo, Danilo Lofaro, Anna Perri and Mauro Francesco La Russa
Endocrines 2025, 6(2), 23; https://doi.org/10.3390/endocrines6020023
Available online: https://www.mdpi.com/2673-396X/6/2/23

2. “Nutrition and Physical Activity in Musculoskeletal Health”
by Ligia J. Dominguez, Nicola Veronese, Lee Smith, Francesco Saverio Ragusa, Giovanna Di Bella, Giuseppe Battaglia, Antonino Bianco and Mario Barbagallo
Endocrines 2025, 6(1), 10; https://doi.org/10.3390/endocrines6010010
Available online: https://www.mdpi.com/2673-396X/6/1/10

3. “Novel Anthropometric Indices: An Allometric Perspective”
by Nir Y. Krakauer and Jesse C. Krakauer
Endocrines 2025, 6(3), 44; https://doi.org/10.3390/endocrines6030044
Available online: https://www.mdpi.com/2673-396X/6/3/44

4. “Lifestyle Behaviors and Gestational Diabetes Mellitus: A Narrative Review”
by Eleftheria Taousani, Konstantinos-Georgios Papaioannou, Gesthimani Mintziori, Maria G. Grammatikopoulou, Angeliki Antonakou, Maria Tzitiridou-Chatzopoulou, Stavroula Veneti and Dimitrios G. Goulis
Endocrines 2025, 6(1), 6; https://doi.org/10.3390/endocrines6010006
Available online: https://www.mdpi.com/2673-396X/6/1/6

5. “Leptin Signaling in the Hypothalamus: Cellular Insights and Therapeutic Perspectives in Obesity”
by Milen Hristov
Endocrines 2025, 6(3), 42; https://doi.org/10.3390/endocrines6030042
Available online: https://www.mdpi.com/2673-396X/6/3/42

6. “Remnant Cholesterol: From Pathophysiology to Clinical Implications in Type 1 Diabetes”
by Fernando Sebastian-Valles, Álvaro Montes Muñiz and Mónica Marazuela
Endocrines 2025, 6(3), 46; https://doi.org/10.3390/endocrines6030046
Available online: https://www.mdpi.com/2673-396X/6/3/46

7. “Endocrine Parameters and Climate Change”
by Borros Arneth
Endocrines 2025, 6(1), 5; https://doi.org/10.3390/endocrines6010005
Available online: https://www.mdpi.com/2673-396X/6/1/5

8. “Effects of the Menstrual Cycle Phase on Cortisol Responses to Maximum Exercise in Women With and Without Premenstrual Syndrome”
by Raul Cosme Ramos Prado, Tamires Nunes Oliveira, Bryan Saunders, Roberta Foster, Zsuzsanna Ilona Katalin de Jármy Di Bella, Marcus W. Kilpatrick, Ricardo Yukio Asano, Anthony C. Hackney and Monica Yuri Takito
Endocrines 2025, 6(1), 14; https://doi.org/10.3390/endocrines6010014
Available online: https://www.mdpi.com/2673-396X/6/1/14

9. “Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues”
by Jan Tesarik
Endocrines 2025, 6(2), 18; https://doi.org/10.3390/endocrines6020018
Available online: https://www.mdpi.com/2673-396X/6/2/18

10. “Lipedema: From Women’s Hormonal Changes to Nutritional Intervention”
by Inês Tomada
Endocrines 2025, 6(2), 24; https://doi.org/10.3390/endocrines6020024
Available online: https://www.mdpi.com/2673-396X/6/2/24

11. “Precocious Puberty and Benign Variants in Female Children: Etiology, Diagnostic Challenges, and Clinical Management”
by Roberto Paparella, Arianna Bei, Lorenzo Brilli, Vittorio Maglione, Francesca Tarani, Marcello Niceta, Ida Pucarelli and Luigi Tarani
Endocrines 2025, 6(2), 29; https://doi.org/10.3390/endocrines6020029
Available online: https://www.mdpi.com/2673-396X/6/2/29

12. “Sleep Deprivation and Its Impact on Insulin Resistance”
by Margarida C. Pinheiro, Henrique E. Costa, Melissa Mariana and Elisa Cairrao
Endocrines 2025, 6(4), 49; https://doi.org/10.3390/endocrines6040049
Available online: https://www.mdpi.com/2673-396X/6/4/49

13. “Current and Emerging Treatments for Metabolic Associated Steatotic Liver Disease and Diabetes: A Narrative Review”
by Rachelle Choi, Jatin Vemuri, Alekya Poloju, Rishi Raj, Anurag Mehta, Amon Asgharpour, Mohammad S. Siddiqui and Priyanka Majety
Endocrines 2025, 6(2), 27; https://doi.org/10.3390/endocrines6020027
Available online: https://www.mdpi.com/2673-396X/6/2/27

14. “Decoding Mini-Puberty and Its Clinical Significance: A Narrative Review”
by Anastasios Serbis, Chrysoula Kosmeri, Natalia Atzemoglou, Katerina-Marina Lampropoulou, Lida-Eleni Giaprou, Dimitrios Rallis and Vasileios Giapros
Endocrines 2025, 6(2), 28; https://doi.org/10.3390/endocrines6020028
Available online: https://www.mdpi.com/2673-396X/6/2/28

15. “Time in Tight Range: A New Frontier in Glycemic Control or Just a Tighter Time in Range? A Narrative Review”
by Gonzalo Diaz Soto, Pablo Fernández Velasco and Pilar Bahillo Curieses
Endocrines 2025, 6(3), 34; https://doi.org/10.3390/endocrines6030034
Available online: https://www.mdpi.com/2673-396X/6/3/34

16. “Energy Homeostasis and Kisspeptin System, Roles of Exercise and Outcomes with a Focus on Male Reproductive Health”
by Mario Ruggiero, Antonella Vicidomini, Domenico Tafuri, Filomena Mazzeo and Rosaria Meccariello
Endocrines 2025, 6(3), 43; https://doi.org/10.3390/endocrines6030043
Available online: https://www.mdpi.com/2673-396X/6/3/43

17. “Comparing Glucometer-Based and Laboratory-Based OGTT for Diabetes Diagnosis: A Narrative Review”
by Tanvir Ahmed, Jaimala Kishore, Mensila Onamika, Shuvratithi Goswami, Iffat Rahman Momo, Hanif Sumon and Rodney G. Bowden
Endocrines 2025, 6(3), 48; https://doi.org/10.3390/endocrines6030048
Available online: https://www.mdpi.com/2673-396X/6/3/48

18. “Gestational Weight Gain and Adverse Pregnancy Outcomes in Women with Gestational Diabetes Mellitus and Obesity”
by Filipe Dias de Souza, Patrícia Medici Dualib, Martha Camillo Jordão, Micaela Frasson Montero, Maria Carolina Oliveira Abate, Leonardo Luna, Rosiane Mattar and Bianca de Almeida-Pititto
Endocrines 2025, 6(4), 52; https://doi.org/10.3390/endocrines6040052
Available online: https://www.mdpi.com/2673-396X/6/4/52

We are pleased to share that Endocrines (ISSN 2673-396X) has received an increased CiteScore of 3.0 in June 2026. The journal is now ranked in Q2 within the “Medicine” category—an impressive achievement for a journal currently in Volume 7.

You can find more statistics on our website: https://www.mdpi.com/journal/endocrines. 

The current CiteScores measure the average number of citations within a journal over a four-year window (2022–2025). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies and research evaluation, as well as enable benchmarking of journal performance. 

Impact Factors measure how often articles in scientific journals are cited—specifically, the average number of citations received in a given year by articles published in that journal over the previous two years, as tracked in the Web of Science. For researchers, the number answers a practical question: how often is work published in this journal being picked up and built upon?

The metric is assigned to the journal as a whole, not to individual articles. A high Impact Factor tells you something useful about a journal's place in its field; it tells you less about any single paper within it.

For a complementary, article-level view, MDPI lists an Altmetric score on each article page. Where the Impact Factor tracks academic citations, the Altmetric score captures broader online attention: how an article is being shared, discussed, and referenced beyond the journal literature. Together, they offer two different ways of asking the same question: is this research reaching people?

With 2025 CiteScores from Scopus published a few weeks ago, Clarivate has now released this year's Journal Impact Factors in the Journal Citation Reports (JCR).

254 MDPI Journals Saw a Rise in Impact Factor

This year's JCR include 330 MDPI journals across a wide range of disciplines. Of these, 231 journals are placed in the top 50% (Q1 or Q2) of their respective subject categories, a result that spans fields as different as materials science, public health, environmental studies, and mathematics. 78 journals hold a top-quartile position (Q1), and 33 journals have a JIF of 5.0 or above.

• 330 journals earned a Journal Impact Factor (JIF)
• 29 journals earned a first JIF
• 254 journals had an increase in JIF
• 71% of ranked journals are in Q1 or Q2

For the full metrics on any MDPI journal, visit our Web of Science journals overview page or a journal's individual statistics page.

29 MDPI Journals Received Their First Journal Impact Factor

A first Impact Factor is a confirmation for an emerging journal. It marks the point at which a journal has been publishing long enough, and cited broadly enough, to enter the formal record of scientific influence. For the research communities those journals serve, it signals that the work being published is being read and built upon.

This year, 29 MDPI journals received a Journal Impact Factor for the first time, across a range of emerging and established research areas. Each represents years of editorial development and peer review—recognized in 2026 for the first time in the JCR.

This is also part of a longer shift in how science gets indexed. When the Emerging Sources Citation Index (ESCI) launched in 2016, 24 MDPI journals were included. By 2024 that number had grown to over 200, reflecting a broader change in the visibility of open access publishing within major citation tracking systems, not just at MDPI but across the sector.

Open Access with Impact

MDPI journals have received a total of 25.2 million citations in Web of Science. That figure matters less as a measure of MDPI's reach and more as a measure of what happens when research is freely available: it gets found, read, and used. Open access is only meaningful if the work actually travels and citations are one indicator that it does.

More than 4.6 million authors have published with MDPI. That breadth, across disciplines, institutions, and geographies, is what makes open access at this scale worth doing.

Thank You to the MDPI Scholarly Community

These results belong to the people who do the actual work: the Editors-in-Chief who set the standards, the Editorial Board Members and reviewers who hold them, and the authors who choose open access for their research. The numbers in the Journal Citation Reports are the downstream effect of decisions made at the desk, in the review, and at submission. Thank you for making them.

Data: 2025 Journal Impact Factors, Journal Citation Reports™ (Clarivate, 2026)

The Society for the Study of Reproduction (SSR) was founded in 1967 to promote the study of reproduction by fostering interdisciplinary communication among scientists, holding conferences, publishing meritorious studies, and contributing to the development and mentoring of young scientists. 

Today we are a global association of more than 1200 active members, including scientists, veterinarians, students, and physicians, representing over 50 countries. Some members are engaged in basic or applied research, while others perform clinical practice. All are dedicated to advancing knowledge of reproductive processes in animals and in humans. 

The SSR 2026 Annual Meeting, themed “Back to the Future, Foundational Knowledge for Future Innovations”, will bring together leading experts, researchers, and industry professionals dedicated to advancing reproductive science. 

The following MDPI journals will be represented:

• Cells;
• Reprod. Med.;
• Sexes;
• Uro;
• Women;
• IJERPH;
• Life;
• Immuno;
• Endocrines;
• Clinics and Practice;
• BioMed;
• JDB;
• Toxics. 

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the conference and answering any questions that you may have. For more information about this event, please visit the following website: https://ssr.org/events/2026-annual-meeting/.

The 2025 CiteScore metrics have been officially released by Scopus, and the results confirm what has become a consistent pattern for MDPI's journal portfolio: broad recognition across disciplines, steady improvement across the majority of ranked titles, and a growing presence at the top of subject category rankings.

CiteScore, published annually by Elsevier's Scopus database, measures the average citations received by articles published in a journal over a four-year window. As a complement to the Journal Impact Factor, which uses a two-year window based on the Web of Science database, CiteScore provides an alternative, long-term perspective on citation performance.

The 365 MDPI journals in Scopus (as of May 2026) are indexed across a wide range of subject categories, ensuring that open access research remains highly discoverable to a global readership through one of the most widely used platforms in academic publishing.

Data Summary (2025 CiteScores)

• New Additions: 41 MDPI journals received a CiteScore for the first time.
• Trending Upward: 234 of 322 previously ranked journals (73%) saw an increase in their CiteScore compared to last year.
• High Visibility: 314 journals (86%) rank in Q1 or Q2 in at least one subject category.
• Elite Performance: 42 journals rank in the top 10% of their subject categories.

Portfolio Performance

Among the 322 journals that held a CiteScore in 2024, 234 saw an increase this year. Quartile improvements outnumbered declines across the portfolio, with 52 journals moving to a higher quartile and only 20 seeing a decline. Furthermore, no previously ranked journals were removed. The 42 journals now ranked in the top 10% of their subject categories are drawn from a strong foundation of 178 journals holding a Q1 position.

With the large majority of our indexed portfolio ranked in the top half of research fields, researchers can confidently choose MDPI to meet funder mandates for high-quality, fully compliant Open Access publishing.

Exceptional Achievements for Foods and Life

Notably, both Foods and Life achieved a 99th percentile ranking in their respective subject categories for the 2025 CiteScores. This outstanding placement positions them as leading journals in their fields and highlights the high visibility and global impact of the open access research they publish.

Journal Metrics and Beyond

Journal-level metrics describe outlets, not individual articles. An increasing number of funders and institutions—including signatories of DORA and the Coalition for Advancing Research Assessment—now explicitly encourage evaluation at the article level rather than by the journal in which research appears. MDPI supports this direction: we report CiteScore alongside the Journal Impact Factor, Journal Citation Indicator, and article-level usage data because no single number captures the full reach and contribution of published research.

Thank You

These results reflect the sustained effort of thousands of editors-in-chief, editorial board members, reviewers, and authors across every field MDPI serves. The metrics are the outcome; the work is yours.